Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype

• Unité de recherche: INNOSUISSE
• Numéro de projet: 103.243 IP-LS
• Titre du projet anglais: Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype

Mots-clé (Anglais)

Life sciences, Human medicine

Résumé des résultats (Abstract) (Anglais)

Melanoma is the fifth most common cancer in Switzerland and the most lethal skin cancer. NRAS-mutated melanoma is the most aggressive subtype, with no effective therapy after immunotherapy failure. We will develop the first effective targeted therapy combination against this often fatal disease.